Mylan's Copaxone Suit Against Teva Should Survive, Judge Says
Teva Pharmaceutical Industries Ltd.'s bid to dismiss antitrust claims should be denied in a case where Mylan Pharmaceuticals Inc. alleges the company unlawfully delayed a generic version of a multiple ...
CSR Wire18h
Spreading Hope: How Teva Is Improving Access to Medicines Across the Globe
In high-income countries, more than 80% of children diagnosed with cancer will survive. Yet in some low- and middle-income ...
Teva Pharmaceutical: A Risky Bet With Potential Upside
Teva's stock is a speculative buy with potential upside if biosimilars succeed, but risks remain high due to debt and ...
Bank of America Securities Sticks to Its Buy Rating for Catalyst Pharma (CPRX)
Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Catalyst Pharma (CPRX – Research Report) yesterday and set a price ...
Amphastar Pharmaceuticals (AMPH) Receives a Hold from Piper Sandler
In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Amphastar Pharmaceuticals (AMPH – Research Report), ...